Selected research
Market Outlook & Growth Opportunities
Global Gene Research Sequencing Platform Market Outlook and Growth Opportunities 2026
Market perspective
The global Gene Research Sequencing Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Gene Research Sequencing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gene Research Sequencing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Research Sequencing Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Gene Research Sequencing Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Gene Research Sequencing Platform market include Illumina, Thermo Fisher Scientific, PacBio, Element Biosciences, Ultima Genomics, GENEWIZ from Azenta, Roche, Oxford Nanopore Technologies and QIAGEN, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Gene Research Sequencing Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gene Research Sequencing Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gene Research Sequencing Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gene Research Sequencing Platform market.
Gene Research Sequencing Platform Segment by Company
Illumina
Thermo Fisher Scientific
PacBio
Element Biosciences
Ultima Genomics
GENEWIZ from Azenta
Roche
Oxford Nanopore Technologies
QIAGEN
Eurofins Genomics
Lexogen
MGI Tech
BGI Genomics
Novogene
Biomarker Technologies
Annoroad
Takara Bio
Rhelixa
FASMAC
RIKEN Genesis
Gene Research Sequencing Platform Segment by Type
Research Sequencing Platform
Translational Medicine Sequencing Platform
Others
Gene Research Sequencing Platform Segment by Application
Medical Industry
Agriculture
Others
Gene Research Sequencing Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Gene Research Sequencing Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Gene Research Sequencing Platform key companies, revenue, market share, and recent developments.
3. To split the Gene Research Sequencing Platform breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Gene Research Sequencing Platform market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gene Research Sequencing Platform significant trends, drivers, influence factors in global and regions.
6. To analyze Gene Research Sequencing Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Research Sequencing Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Research Sequencing Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Research Sequencing Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Research Sequencing Platform industry.
Chapter 3: Detailed analysis of Gene Research Sequencing Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Gene Research Sequencing Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Gene Research Sequencing Platform in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Research Sequencing Platform
- Translational Medicine Sequencing Platform
- Others
Applications
- Medical Industry
- Agriculture
- Others
Companies covered
- Illumina
- Thermo Fisher Scientific
- PacBio
- Element Biosciences
- Ultima Genomics
- GENEWIZ from Azenta
- Roche
- Oxford Nanopore Technologies
- QIAGEN
- Eurofins Genomics
- Lexogen
- MGI Tech
- BGI Genomics
- Novogene
- Biomarker Technologies
- Annoroad
- Takara Bio
- Rhelixa
- FASMAC
- RIKEN Genesis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gene Research Sequencing Platform Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gene Research Sequencing Platform Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Gene Research Sequencing Platform Market Dynamics
- 2.1 Gene Research Sequencing Platform Industry Trends
- 2.2 Gene Research Sequencing Platform Industry Drivers
- 2.3 Gene Research Sequencing Platform Industry Opportunities and Challenges
- 2.4 Gene Research Sequencing Platform Industry Restraints
3 Gene Research Sequencing Platform Market by Company
- 3.1 Global Gene Research Sequencing Platform Company Revenue Ranking in 2025
- 3.2 Global Gene Research Sequencing Platform Revenue by Company (2021-2026)
- 3.3 Global Gene Research Sequencing Platform Company Ranking (2024-2026)
- 3.4 Global Gene Research Sequencing Platform Company Manufacturing Base and Headquarters
- 3.5 Global Gene Research Sequencing Platform Company Product Type and Application
- 3.6 Global Gene Research Sequencing Platform Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Gene Research Sequencing Platform Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Gene Research Sequencing Platform Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Gene Research Sequencing Platform Market by Type
- 4.1 Gene Research Sequencing Platform Type Introduction
- 4.1.1 Research Sequencing Platform
- 4.1.2 Translational Medicine Sequencing Platform
- 4.1.3 Others
- 4.2 Global Gene Research Sequencing Platform Sales Value by Type
- 4.2.1 Global Gene Research Sequencing Platform Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gene Research Sequencing Platform Sales Value by Type (2021-2032)
- 4.2.3 Global Gene Research Sequencing Platform Sales Value Share by Type (2021-2032)
5 Gene Research Sequencing Platform Market by Application
- 5.1 Gene Research Sequencing Platform Application Introduction
- 5.1.1 Medical Industry
- 5.1.2 Agriculture
- 5.1.3 Others
- 5.2 Global Gene Research Sequencing Platform Sales Value by Application
- 5.2.1 Global Gene Research Sequencing Platform Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gene Research Sequencing Platform Sales Value by Application (2021-2032)
- 5.2.3 Global Gene Research Sequencing Platform Sales Value Share by Application (2021-2032)
6 Gene Research Sequencing Platform Regional Value Analysis
- 6.1 Global Gene Research Sequencing Platform Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gene Research Sequencing Platform Sales Value by Region (2021-2032)
- 6.2.1 Global Gene Research Sequencing Platform Sales Value by Region: 2021-2026
- 6.2.2 Global Gene Research Sequencing Platform Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gene Research Sequencing Platform Sales Value (2021-2032)
- 6.3.2 North America Gene Research Sequencing Platform Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Gene Research Sequencing Platform Sales Value (2021-2032)
- 6.4.2 Europe Gene Research Sequencing Platform Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Gene Research Sequencing Platform Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Gene Research Sequencing Platform Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Gene Research Sequencing Platform Sales Value (2021-2032)
- 6.6.2 South America Gene Research Sequencing Platform Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Gene Research Sequencing Platform Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Gene Research Sequencing Platform Sales Value Share by Country, 2025 VS 2032
7 Gene Research Sequencing Platform Country-level Value Analysis
- 7.1 Global Gene Research Sequencing Platform Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Gene Research Sequencing Platform Sales Value by Country (2021-2032)
- 7.2.1 Global Gene Research Sequencing Platform Sales Value by Country (2021-2026)
- 7.2.2 Global Gene Research Sequencing Platform Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.7.2 France Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.14.2 China Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.17.2 India Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Gene Research Sequencing Platform Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Gene Research Sequencing Platform Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Gene Research Sequencing Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Illumina
- 8.1.1 Illumina Company Information
- 8.1.2 Illumina Business Overview
- 8.1.3 Illumina Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.1.4 Illumina Gene Research Sequencing Platform Product Portfolio
- 8.1.5 Illumina Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Gene Research Sequencing Platform Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 PacBio
- 8.3.1 PacBio Company Information
- 8.3.2 PacBio Business Overview
- 8.3.3 PacBio Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.3.4 PacBio Gene Research Sequencing Platform Product Portfolio
- 8.3.5 PacBio Recent Developments
- 8.4 Element Biosciences
- 8.4.1 Element Biosciences Company Information
- 8.4.2 Element Biosciences Business Overview
- 8.4.3 Element Biosciences Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.4.4 Element Biosciences Gene Research Sequencing Platform Product Portfolio
- 8.4.5 Element Biosciences Recent Developments
- 8.5 Ultima Genomics
- 8.5.1 Ultima Genomics Company Information
- 8.5.2 Ultima Genomics Business Overview
- 8.5.3 Ultima Genomics Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.5.4 Ultima Genomics Gene Research Sequencing Platform Product Portfolio
- 8.5.5 Ultima Genomics Recent Developments
- 8.6 GENEWIZ from Azenta
- 8.6.1 GENEWIZ from Azenta Company Information
- 8.6.2 GENEWIZ from Azenta Business Overview
- 8.6.3 GENEWIZ from Azenta Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.6.4 GENEWIZ from Azenta Gene Research Sequencing Platform Product Portfolio
- 8.6.5 GENEWIZ from Azenta Recent Developments
- 8.7 Roche
- 8.7.1 Roche Company Information
- 8.7.2 Roche Business Overview
- 8.7.3 Roche Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.7.4 Roche Gene Research Sequencing Platform Product Portfolio
- 8.7.5 Roche Recent Developments
- 8.8 Oxford Nanopore Technologies
- 8.8.1 Oxford Nanopore Technologies Company Information
- 8.8.2 Oxford Nanopore Technologies Business Overview
- 8.8.3 Oxford Nanopore Technologies Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.8.4 Oxford Nanopore Technologies Gene Research Sequencing Platform Product Portfolio
- 8.8.5 Oxford Nanopore Technologies Recent Developments
- 8.9 QIAGEN
- 8.9.1 QIAGEN Company Information
- 8.9.2 QIAGEN Business Overview
- 8.9.3 QIAGEN Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.9.4 QIAGEN Gene Research Sequencing Platform Product Portfolio
- 8.9.5 QIAGEN Recent Developments
- 8.10 Eurofins Genomics
- 8.10.1 Eurofins Genomics Company Information
- 8.10.2 Eurofins Genomics Business Overview
- 8.10.3 Eurofins Genomics Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.10.4 Eurofins Genomics Gene Research Sequencing Platform Product Portfolio
- 8.10.5 Eurofins Genomics Recent Developments
- 8.11 Lexogen
- 8.11.1 Lexogen Company Information
- 8.11.2 Lexogen Business Overview
- 8.11.3 Lexogen Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.11.4 Lexogen Gene Research Sequencing Platform Product Portfolio
- 8.11.5 Lexogen Recent Developments
- 8.12 MGI Tech
- 8.12.1 MGI Tech Company Information
- 8.12.2 MGI Tech Business Overview
- 8.12.3 MGI Tech Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.12.4 MGI Tech Gene Research Sequencing Platform Product Portfolio
- 8.12.5 MGI Tech Recent Developments
- 8.13 BGI Genomics
- 8.13.1 BGI Genomics Company Information
- 8.13.2 BGI Genomics Business Overview
- 8.13.3 BGI Genomics Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.13.4 BGI Genomics Gene Research Sequencing Platform Product Portfolio
- 8.13.5 BGI Genomics Recent Developments
- 8.14 Novogene
- 8.14.1 Novogene Company Information
- 8.14.2 Novogene Business Overview
- 8.14.3 Novogene Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.14.4 Novogene Gene Research Sequencing Platform Product Portfolio
- 8.14.5 Novogene Recent Developments
- 8.15 Biomarker Technologies
- 8.15.1 Biomarker Technologies Company Information
- 8.15.2 Biomarker Technologies Business Overview
- 8.15.3 Biomarker Technologies Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.15.4 Biomarker Technologies Gene Research Sequencing Platform Product Portfolio
- 8.15.5 Biomarker Technologies Recent Developments
- 8.16 Annoroad
- 8.16.1 Annoroad Company Information
- 8.16.2 Annoroad Business Overview
- 8.16.3 Annoroad Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.16.4 Annoroad Gene Research Sequencing Platform Product Portfolio
- 8.16.5 Annoroad Recent Developments
- 8.17 Takara Bio
- 8.17.1 Takara Bio Company Information
- 8.17.2 Takara Bio Business Overview
- 8.17.3 Takara Bio Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.17.4 Takara Bio Gene Research Sequencing Platform Product Portfolio
- 8.17.5 Takara Bio Recent Developments
- 8.18 Rhelixa
- 8.18.1 Rhelixa Company Information
- 8.18.2 Rhelixa Business Overview
- 8.18.3 Rhelixa Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.18.4 Rhelixa Gene Research Sequencing Platform Product Portfolio
- 8.18.5 Rhelixa Recent Developments
- 8.19 FASMAC
- 8.19.1 FASMAC Company Information
- 8.19.2 FASMAC Business Overview
- 8.19.3 FASMAC Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.19.4 FASMAC Gene Research Sequencing Platform Product Portfolio
- 8.19.5 FASMAC Recent Developments
- 8.20 RIKEN Genesis
- 8.20.1 RIKEN Genesis Company Information
- 8.20.2 RIKEN Genesis Business Overview
- 8.20.3 RIKEN Genesis Gene Research Sequencing Platform Revenue and Gross Margin (2021-2026)
- 8.20.4 RIKEN Genesis Gene Research Sequencing Platform Product Portfolio
- 8.20.5 RIKEN Genesis Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst